SCHEMBL20100895

SCHEMBL20100895

COc1ccc(-c2cc(=O)c3c(OC)cc(C)cc3o2)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.82
ADORA3 P0DMS8 1/20 0.74
ALDH1A1 P00352 4/20 0.70
MEN1 O00255 4/20 0.70
KMT2A Q03164 4/20 0.70
NPC1 O15118 3/20 0.67
RAB9A P51151 3/20 0.67
KDM4E B2RXH2 2/20 0.67
ABCG2 Q9UNQ0 1/20 0.67
FLT3 P36888 3/20 0.64
MAOB P27338 8/20 0.64
CYP19A1 P11511 1/20 0.64
MAPT P10636 3/20 0.62
CYP3A4 P08684 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
HPGD P15428 1/20 0.62
HSD17B10 Q99714 1/20 0.62
MAOA P21397 5/20 0.61
KCNA5 P22460 3/20 0.61
KCNH2 Q12809 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylapigenin SCHEMBL29350875 0.90 ABCB1 (1.00) ABCB1ADORA3ALDH1A1MEN1KMT2A
Trimethylapigenin SCHEMBL1421585 0.90 ABCB1 (1.00) ABCB1ADORA3ALDH1A1MEN1KMT2A
SCHEMBL19129475 0.88 KDM4E (0.72) ABCB1ADORA3ALDH1A1MEN1KMT2A
SCHEMBL19129538 0.88 ABCB1 (0.64) ABCB1ADORA3ALDH1A1MEN1KMT2A
SCHEMBL20100898 0.88 KDM4E (0.78) ABCB1ADORA3ALDH1A1MEN1KMT2A
SCHEMBL20664412 0.88 ADORA3 (0.76) ABCB1ADORA3ALDH1A1MEN1KMT2A
SCHEMBL19129474 0.86 MAOB (0.64) ABCB1ADORA3ALDH1A1MEN1KMT2A
SCHEMBL19129537 0.86 MAOB (0.64) ABCB1ADORA3ALDH1A1MEN1KMT2A
SCHEMBL19129531 0.86 MAOB (0.67) ABCB1ADORA3ALDH1A1MEN1KMT2A
SCHEMBL4279323 0.85 ABCB1 (0.80) ABCB1ADORA3ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180117000-A1 ENERGY METABOLIC ACTIVATING AGENT FOR MUSCLE CELLS ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180117000-A1 ENERGY METABOLIC ACTIVATING AGENT FOR MUSCLE CELLS SLC2A1, SLC2A2, SLC2A4 ABCB1 981/4885ADORA3 1129/4885ALDH1A1 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.